NANOBIOTIX announced the appointment of twelve global medical experts to a Scientific Advisory Board designed to support the Company regarding development of lead therapeutic candidate NBTXR3. Members of the Nanobiotix Scientific Advisory Board: Sylvie Bonvalot, MD, PhD, HDR; Surgical Oncologist, Head of Sarcoma Surgery at Institut Curie, Paris, France; Jared Marc Weiss, MD; Medical Oncologist, Professor, Medicine-Oncology at the University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America (USA); Robert L. Ferris, MD, PhD, FACS; Surgical Oncologist, Director at the UPMC Hillman Cancer Center, Hillman Professor of Oncology, Associate Vice Chancellor for Cancer Research and Professor of Otolaryngology, of Immunology and of Radiation Oncology at the University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Nancy Y. Lee, MD, FASTRO; Radiation Oncologist, Vice Chair, Department of Radiation Oncology; Service Chief, Head & Neck Radiation Oncology; Service Chief, Proton Therapy at Memorial Sloan Kettering Cancer Center, New York, New York, USA; Silvia Chiara Formenti, MD, FASTRO; Radiation Oncologist, Chairman of Radiation Oncology at Weill Cornell Medicine, New York, New York, USA; Quynh-Thu Xuan Le, MD; Radiation Oncologist, Chair of the Stanford Radiation Oncology Department and Katharine Dexter McCormick & Stanley Memorial Professorship at Stanford University, Palo Alto, California, USA; Christophe Le Tourneau, MD, PhD; Medical Oncologist, Head of the Department of Drug Development (D3i) at the Institut Curie and Professor of Medicine at Paris-Saclay University, Paris, France; Hisham Mehanna, PhD, BMedSc, MBChB, FRCS; Surgical Oncologist, Deputy Pro-Vice Chancellor, Chair of Head and Neck Surgery, and Director of the Institute of Head and Neck Studies and Education at the University of Birmingham, United Kingdom; Thierry De Baère, MD; Interventional Radiologist, Head of the Interventional Radiology Unit at Gustave Roussy Cancer Centre and University Paris-Saclay in Paris, France, and Head of Interventional Radiology at Gustave Roussy Cancer Center, Villejuif, France; Chiaojung Jillian Tsai, MD, PhD; Radiation Oncologist, Incoming Site Lead, Palliative Radiation Oncology Program, Radiation Medicine, Princess Margaret Cancer Centre, Toronto, Canada; Stéphane Champiat, MD, MS, PhD; Medical Oncologist, Head of the Inpatient Unit at the Drug Development Department of Gustave Roussy Cancer Campus, Paris, France; Jean Bourhis, MD, PhD; Radiation Oncologist, Professor, Chief of Radiation Oncology at the Lausanne University Hospital, Lausanne, Switzerland.